HealthLynked Corp. has submitted registration documents for a public offering of common stock totaling up to $7.0 million and has applied to have its shares listed on the NASDAQ Capital Market, the company said in a statement.
The Nevada-based firm indicated it expects to offer shares at an assumed price between $4.00 and $6.00 per share. HealthLynked's common shares are presently quoted on the OTCQB under the ticker HLYK, with a closing price of $2.75 on February 6, 2026.
In its filing, the company emphasized that the ultimate price per share will be set through discussions with the underwriter and may not match recent trading levels. HealthLynked also said it anticipates its shares will start trading on NASDAQ around the prospectus date, and that trading on the OTCQB would end once the NASDAQ listing commences.
The filing includes a caution that there is no guarantee an active market for the stock will develop if listed, nor that NASDAQ will grant approval of the listing application. The company stated it will not proceed with the public offering if NASDAQ does not approve the listing.
HealthLynked noted that its common stock currently shows limited trading activity on the OTCQB. If the NASDAQ listing is completed, the company plans to retain the ticker symbol "HLYK" for trading on the exchange.
Investor tools and screening services were referenced in the filing's accompanying materials. One such service, ProPicks AI, is described as evaluating HLYK among thousands of companies using more than 100 financial metrics. The description states the AI assesses fundamentals, momentum, and valuation without bias to identify stocks that offer attractive risk-reward profiles. The materials cite past notable winners identified by the AI, including Super Micro Computer (+185%) and AppLovin (+157%).
Below is a concise breakdown of the filing's principal items and considerations for market observers:
- Offering size and range: Up to $7 million in common stock, with an assumed price range of $4.00 to $6.00 per share.
- Current trading venue and price: Shares trade on the OTCQB under HLYK; closed at $2.75 on February 6, 2026.
- NASDAQ listing intention: Application submitted for the NASDAQ Capital Market; the company would cease OTCQB trading once NASDAQ trading begins.
The filing makes clear that several outcomes remain uncertain, including whether NASDAQ will approve the listing application and whether an active trading market will materialize for the company's shares after a potential uplist. The company has attached a contingency that it will not complete the offering absent NASDAQ approval.
For market participants and observers, the filing signals HealthLynked's intent to transition to a national exchange and raise capital, while also highlighting typical contingencies tied to uplisting transactions and small-cap offerings.